CryoPort Inc (CYRX)

[coldasice]

CN, a simple click of Google, tells me the 3rd quarter can not be that good.. One, India has banned surrogacy to foreigners. India is the International hub for surrogacy..
While IVF is not, In my opinion, the bread and butter of CYRX... In the earlier stages, like now, the low hanging fruit, helpful...
Link: http://www.bbc.com/news/world-asia-india-34876458.
Two, Caladrius, the old NeoStem, discontinued their phase 3 trial... CryoPort was the logistics provider.. One can easily Google the official press release about CryoPort and NeoStem, and the Caladrius discontinuation..
Again, while I don't think one failure is a big deal, in the earlier stages of revenue growth, every little bit counts...
And it seems that these events happened in the CYRX 3rd quarter...
My hope, that the 3rd quarter was the bottom... And the company could start to really move forward the quarter we are in now.. These failures and delays are common issues, when dealing with emerging markets and emerging biopharma...



As far a gross margins.. I would love to see expansion, but again, a young company, probably has to work within some parameters.. In the short run, while the stock could go down slightly.. I think your $2.00 purchase in the long run, will make you some money... Again, I have not purchased any stock, but a few tradable warrants several months ago.. I really hope I am wrong about the 3rd quarter, but will not purchase any shares, until I see the 3Q numbers and listen to the conference call..